Esperion Therapeutics, Inc. Quarterly Operating Margin in % from Q4 2019 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Esperion Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2019 to Q3 2024.
  • Esperion Therapeutics, Inc. Operating Margin for the quarter ending September 30, 2024 was 5.57 %.
  • Esperion Therapeutics, Inc. annual Operating Margin for 2023 was -134 %, a 43.8% increase from 2022.
  • Esperion Therapeutics, Inc. annual Operating Margin for 2022 was -238 %, a 17.7% increase from 2021.
  • Esperion Therapeutics, Inc. annual Operating Margin for 2021 was -289 %, a 442% decline from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 5.57 +157 Jul 1, 2024 Sep 30, 2024
Q2 2024 1.78 +195 Apr 1, 2024 Jun 30, 2024
Q1 2024 -15.1 +214 +93.4% Jan 1, 2024 Mar 31, 2024
Q4 2023 -134 +104 +43.8% Oct 1, 2023 Dec 31, 2023
Q3 2023 -151 +116 +43.4% Jul 1, 2023 Sep 30, 2023
Q2 2023 -193 +113 +36.9% Apr 1, 2023 Jun 30, 2023
Q1 2023 -229 -19.4 -9.25% Jan 1, 2023 Mar 31, 2023
Q4 2022 -238 +51.2 +17.7% Oct 1, 2022 Dec 31, 2022
Q3 2022 -267 +99.6 +27.1% Jul 1, 2022 Sep 30, 2022
Q2 2022 -306 +163 +34.7% Apr 1, 2022 Jun 30, 2022
Q1 2022 -209 -154 -277% Jan 1, 2022 Mar 31, 2022
Q4 2021 -289 -236 -442% Oct 1, 2021 Dec 31, 2021
Q3 2021 -367 -328 -847% Jul 1, 2021 Sep 30, 2021
Q2 2021 -469 -437 -1348% Apr 1, 2021 Jun 30, 2021
Q1 2021 -55.5 +5.26K +99% Jan 1, 2021 Mar 31, 2021
Q4 2020 -53.4 +9.4 +15% Oct 1, 2020 Dec 31, 2020
Q3 2020 -38.7 Jul 1, 2020 Sep 30, 2020
Q2 2020 -32.4 Apr 1, 2020 Jun 30, 2020
Q1 2020 -5.32K Jan 1, 2020 Mar 31, 2020
Q4 2019 -62.8 Oct 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.